Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

293 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A Randomized Comparison of Doxorubicin and Doxorubicin-DNA in the Treatment of Acute NonLymphoblastic Leukemia.
Paul C, Tidefelt U, Gahrton G, Björkholm M, Järnmark M, Killander A, Kimby E, Liliemark J, Lindeberg A, Lindquist R, Lockner D, Lönnqvist B, Mellstedt H, Merk K, Palmblad J, Peterson C, Simonsson B, Stalfelt AM, Sundström C, Wadman B, Wedelin C, Udén AM, Öberg G, Öst Å. Paul C, et al. Among authors: simonsson b. Leuk Lymphoma. 1991;3(5-6):355-64. doi: 10.3109/10428199109070279. Leuk Lymphoma. 1991. PMID: 27467426
A phase I/II study of the MDR modulator Valspodar (PSC 833) combined with daunorubicin and cytarabine in patients with relapsed and primary refractory acute myeloid leukemia.
Gruber A, Björkholm M, Brinch L, Evensen S, Gustavsson B, Hedenus M, Juliusson G, Löfvenberg E, Nesthus I, Simonsson B, Sjo M, Stenke L, Tangen JM, Tidefelt U, Udén AM, Paul C, Liliemark J. Gruber A, et al. Among authors: simonsson b. Leuk Res. 2003 Apr;27(4):323-8. doi: 10.1016/s0145-2126(02)00181-9. Leuk Res. 2003. PMID: 12531223 Clinical Trial.
Successful mobilization of Ph-negative blood stem cells with intensive chemotherapy + G-CSF in patients with chronic myelogenous leukemia in first chronic phase.
Olsson-Strömberg U, Höglund M, Björkholm M, Braide I, Carlson K, Gahrton G, Grimfors G, Hast R, Lerner R, Linder O, Ljungman P, Löfvenberg E, Malm C, Nilsson PG, Paul C, Rödjer S, Stenke L, Tidefeldt U, Turesson I, Uden AM, Wahlin A, Vilen L, Winqvist I, Zettervall O, Oberg G, Simonsson B. Olsson-Strömberg U, et al. Among authors: simonsson b. Leuk Lymphoma. 2006 Sep;47(9):1768-73. doi: 10.1080/10428190600611117. Leuk Lymphoma. 2006. PMID: 17064986
Comparison of daunorubicin and daunorubicin-DNA complex in the treatment of acute nonlymphoblastic leukemia.
Paul C, Björkholm M, Christenson I, Engstedt L, Gahrton G, Hast R, Holm G, Killander A, Lantz B, Lockner D, Lönnqvist B, Mellstedt H, Palmblad J, Peterson C, Simonsson B, Stalfelt AM, Udén AM, Wadman B, Oberg G. Paul C, et al. Among authors: simonsson b. Cancer Chemother Pharmacol. 1981;6(1):65-73. doi: 10.1007/BF00253012. Cancer Chemother Pharmacol. 1981. PMID: 7023715 Clinical Trial.
Prednimustine and vincristine compared with cytosine arabinoside and thioguanine for treatment of elderly patients with acute nonlymphoblastic leukemia.
Lönnqvist B, Andersson B, Björkholm M, Engstedt L, Gahrton G, Hast R, Holm G, Killander A, Lantz B, Lockner D, Mellstedt H, Palmblad J, Paul C, Peterson C, Simonsson B, Stalfelt AM, Udén AM, Wadman B, Oberg G. Lönnqvist B, et al. Among authors: simonsson b. Cancer Chemother Pharmacol. 1982;9(2):89-92. doi: 10.1007/BF00265385. Cancer Chemother Pharmacol. 1982. PMID: 7172410 Clinical Trial.
293 results